收费全文 | 46638篇 |
免费 | 3417篇 |
国内免费 | 132篇 |
耳鼻咽喉 | 627篇 |
儿科学 | 1252篇 |
妇产科学 | 726篇 |
基础医学 | 5941篇 |
口腔科学 | 1345篇 |
临床医学 | 4495篇 |
内科学 | 9157篇 |
皮肤病学 | 651篇 |
神经病学 | 4849篇 |
特种医学 | 2485篇 |
外国民族医学 | 1篇 |
外科学 | 6878篇 |
综合类 | 722篇 |
一般理论 | 24篇 |
预防医学 | 4493篇 |
眼科学 | 1328篇 |
药学 | 2737篇 |
中国医学 | 57篇 |
肿瘤学 | 2419篇 |
2021年 | 497篇 |
2020年 | 350篇 |
2019年 | 474篇 |
2018年 | 589篇 |
2017年 | 475篇 |
2016年 | 547篇 |
2015年 | 723篇 |
2014年 | 1092篇 |
2013年 | 1741篇 |
2012年 | 2295篇 |
2011年 | 2550篇 |
2010年 | 1482篇 |
2009年 | 1375篇 |
2008年 | 2433篇 |
2007年 | 2755篇 |
2006年 | 2709篇 |
2005年 | 2737篇 |
2004年 | 2551篇 |
2003年 | 2509篇 |
2002年 | 2569篇 |
2001年 | 916篇 |
2000年 | 800篇 |
1999年 | 824篇 |
1998年 | 632篇 |
1997年 | 498篇 |
1996年 | 463篇 |
1995年 | 477篇 |
1994年 | 441篇 |
1993年 | 403篇 |
1992年 | 565篇 |
1991年 | 567篇 |
1990年 | 492篇 |
1989年 | 497篇 |
1988年 | 485篇 |
1987年 | 442篇 |
1986年 | 470篇 |
1985年 | 496篇 |
1984年 | 517篇 |
1983年 | 496篇 |
1982年 | 573篇 |
1981年 | 540篇 |
1980年 | 536篇 |
1979年 | 474篇 |
1978年 | 393篇 |
1977年 | 406篇 |
1976年 | 297篇 |
1975年 | 341篇 |
1974年 | 334篇 |
1973年 | 336篇 |
1972年 | 313篇 |
Background
There are well-established relationships between health and homelessness, and shelters can facilitate the transmission of diseases and contribute to their prevention. Adequate environmental health conditions and hygiene behaviors in homeless shelters are fundamental to the health of their clients, a marginalized population. We report the status of environmental health conditions and hygiene behaviors in homeless shelters and associated health outcomes; interventions to improve these conditions, behaviors, and outcomes; and obstacles to improvement.Methods
PubMed, Web of Science, Scopus, and EBSCOhost were searched for peer-reviewed studies, and additional sources for grey literature. Studies were included if they reported primary data on one or more environmental health condition or hygiene behavior in homeless shelters.Results
Twenty-eight studies were included in the review. Insufficient ventilation systems, unhygienic bedding, and overcrowding were the most documented environmental health and hygiene deficiencies in homeless shelters, and tuberculosis infections and skin diseases were the most documented associated health outcomes among clients. Studies frequently recommended or described implementation of behavioral and administrative controls, ventilation system improvements, and ultraviolet germicidal irradiation fixtures.Discussion
Most studies addressed airborne transmission of tuberculosis and were conducted in high-income countries, revealing an imbalance in the literature. Insufficient resources and the transience of clients are barriers to improving hygiene behaviors and environmental conditions in homeless shelters. Further investment and research into ensuring adequate hygiene and environmental health in this setting can protect and promote the health and well-being of people experiencing homelessness. 相似文献Areas covered: This review focuses on current treatments and the future outlook for allergic rhinitis. Pharmacotherapy includes mast cell stabilizers, antihistamines, glucocorticosteroids (GCSs), leukotriene receptor antagonists, and nasal decongestants. Nasal GCSs are currently regarded as the most effective treatment and are considered first-line therapy together with non-sedating antihistamines. The new formulation MP29-02 combines the nasal GCS fluticasone propionate with azelastine in one single spray and has achieved greater improvements than those under monotherapy with modern GCSs or antihistamines. Furthermore, this review discusses allergen immunotherapy alone and in combination with modern monoclonal antibodies.
Expert opinion: Despite the variety of medications for allergic rhinitis, ranging from general symptomatic agents like GCSs or decongestants, to more specific ones like histamine receptor or leukotriene blockers, to causal therapy like immunotherapy, many patients still experience treatment failures or unsatisfactory results. The ultimate goal may be to endotype every downstream pathway separately in order to offer patients individualized, targeted therapy with specific antibodies against the respective pathway. 相似文献